Qisda Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Şu anda Qisda için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.
Anahtar bilgiler
n/a
Kazanç büyüme oranı
n/a
EPS büyüme oranı
| Tech kazanç büyümesi | 21.6% |
| Gelir büyüme oranı | n/a |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Low |
| Son güncelleme | 14 Apr 2026 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Analiz Güncellemesi • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Analiz Güncellemesi • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Analiz Güncellemesi • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Analiz Güncellemesi • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Yeni Analiz • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Analiz Güncellemesi • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Analiz Güncellemesi • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Analiz Güncellemesi • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Analiz Güncellemesi • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Analiz Güncellemesi • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Analiz Güncellemesi • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Analiz Güncellemesi • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Analiz Güncellemesi • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Analiz Güncellemesi • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Analiz Güncellemesi • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Analiz Güncellemesi • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
Yeni Analiz • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Analiz Makalesi • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Analiz Makalesi • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Analiz Makalesi • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analiz Makalesi • Mar 15
Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?
Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...Analiz Makalesi • Feb 26
Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...Analiz Makalesi • Feb 08
These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jan 24
Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...Analiz Makalesi • Jan 09
Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...Analiz Makalesi • Dec 25
We Like These Underlying Trends At Qisda (TPE:2352)
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 217,744 | 2,696 | -4,932 | 2,252 | 1 |
| 12/31/2025 | 207,905 | 1,143 | 3,313 | 9,106 | N/A |
| 9/30/2025 | 209,844 | 1,281 | 3,126 | 8,900 | N/A |
| 6/30/2025 | 208,105 | 2,083 | 22 | 5,721 | N/A |
| 3/31/2025 | 204,499 | 2,390 | -311 | 5,367 | N/A |
| 12/31/2024 | 201,666 | 2,164 | -2,480 | 3,301 | N/A |
| 9/30/2024 | 198,233 | 2,399 | -2,058 | 3,673 | N/A |
| 6/30/2024 | 197,809 | 2,548 | -793 | 4,615 | N/A |
| 3/31/2024 | 200,063 | 2,909 | 1,328 | 7,123 | N/A |
| 12/31/2023 | 203,595 | 2,976 | 8,276 | 13,611 | N/A |
| 9/30/2023 | 209,045 | 2,922 | 16,446 | 22,534 | N/A |
| 6/30/2023 | 218,734 | 8,084 | 12,293 | 18,883 | N/A |
| 3/31/2023 | 229,417 | 8,042 | 2,746 | 9,024 | N/A |
| 12/31/2022 | 239,837 | 8,252 | -8,195 | -1,191 | N/A |
| 9/30/2022 | 245,593 | 8,876 | -15,082 | -7,758 | N/A |
| 6/30/2022 | 242,734 | 3,907 | -16,648 | -9,963 | N/A |
| 3/31/2022 | 235,923 | 6,730 | -12,280 | -5,105 | N/A |
| 12/31/2021 | 225,961 | 8,308 | -4,599 | 2,115 | N/A |
| 9/30/2021 | 221,223 | 9,073 | -4,171 | 2,174 | N/A |
| 6/30/2021 | 215,716 | 9,724 | 4,015 | 10,595 | N/A |
| 3/31/2021 | 203,405 | 6,868 | 7,648 | 13,242 | N/A |
| 12/31/2020 | 191,702 | 4,988 | 9,613 | 14,569 | N/A |
| 9/30/2020 | 180,430 | 3,861 | 7,961 | 11,683 | N/A |
| 6/30/2020 | 171,539 | 2,825 | 8,624 | 11,687 | N/A |
| 3/31/2020 | 169,101 | 2,918 | 9,040 | 11,709 | N/A |
| 12/31/2019 | 169,754 | 3,575 | 5,820 | 8,475 | N/A |
| 9/30/2019 | 166,279 | 3,981 | N/A | 6,572 | N/A |
| 6/30/2019 | 163,148 | 4,166 | N/A | 7,005 | N/A |
| 3/31/2019 | 159,983 | 3,927 | N/A | 7,073 | N/A |
| 12/31/2018 | 155,783 | 4,035 | N/A | 8,958 | N/A |
| 9/30/2018 | 150,516 | 4,412 | N/A | 8,414 | N/A |
| 6/30/2018 | 146,001 | 4,497 | N/A | 7,913 | N/A |
| 3/31/2018 | 140,830 | 5,058 | N/A | 4,389 | N/A |
| 12/31/2017 | 136,862 | 5,291 | N/A | 336 | N/A |
| 9/30/2017 | 134,025 | 5,475 | N/A | 4,681 | N/A |
| 6/30/2017 | 130,853 | 5,626 | N/A | 2,228 | N/A |
| 3/31/2017 | 129,476 | 5,059 | N/A | 5,254 | N/A |
| 12/31/2016 | 129,554 | 4,342 | N/A | 7,948 | N/A |
| 9/30/2016 | 129,484 | 2,998 | N/A | 7,144 | N/A |
| 6/30/2016 | 130,750 | 2,141 | N/A | 6,600 | N/A |
| 3/31/2016 | 132,439 | 2,063 | N/A | 7,470 | N/A |
| 12/31/2015 | 133,102 | 2,169 | N/A | 5,250 | N/A |
| 9/30/2015 | 134,323 | 2,727 | N/A | 1,540 | N/A |
| 6/30/2015 | 135,974 | 3,194 | N/A | 2,112 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 2352 'un tahmini kazanç büyümesinin tasarruf oranının ( 1.3% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.
Kazançlar ve Piyasa: 2352 'un kazançlarının TW pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok
Yüksek Büyüme Kazançları: 2352 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.
Gelir ve Pazar: 2352 şirketinin gelirinin TW pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.
Yüksek Büyüme Geliri: 2352 şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 2352 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok
Büyüyen şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/06 06:49 |
| Gün Sonu Hisse Fiyatı | 2026/05/06 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Qisda Corporation 6 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |
| null null | KGI Securities Co. Ltd. |